Literature DB >> 23081761

Dual-energy perfusion CT of non-diseased lung segments using dual-source CT: correlation with perfusion SPECT.

Yoshie Kunihiro1, Munemasa Okada, Naofumi Matsunaga, Yuichi Sano, Shohei Kudomi, Kazuyoshi Suga, Shoji Kido.   

Abstract

PURPOSE: To determine the utility of dual-energy perfusion CT (DEpCT) of non-diseased lung segments, using dual-source CT, in comparison with perfusion single-photon emission computed tomography (SPECT).
MATERIALS AND METHODS: 28 patients (18 male and 10 female; mean age 63 years; age range 18-86 years) underwent DEpCT and SPECT within a 3-day interval. The presence and location of perfusion defects in each segment of the lungs were evaluated.
RESULTS: Perfusion defects were noted in 7 of 361 segments (1.9%) by DEpCT and in 19 of 361 segments (5.3%) by perfusion SPECT. DEpCT was in good agreement with perfusion SPECT for 338 of 361 segments (93.6%). Intraobserver agreement was also good, ranging from 93.4 to 93.6% (κ = 0.64-0.75, p < 0.01).
CONCLUSION: For non-diseased lung segments, DEpCT correlated well with SPECT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23081761     DOI: 10.1007/s11604-012-0153-9

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  14 in total

1.  Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI.

Authors:  H Hatabu; E Tadamura; D L Levin; Q Chen; W Li; D Kim; P V Prasad; R R Edelman
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  Quantification of radiation-induced regional lung injury with perfusion imaging.

Authors:  L B Marks; M T Munley; D P Spencer; G W Sherouse; G C Bentel; J Hoppenworth; M Chew; R J Jaszczak; R E Coleman; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

3.  Comparison of ventilation/perfusion scintigraphy and helical CT for diagnosis of pulmonary embolism; strategy using clinical data and ancillary findings.

Authors:  Marika Bajc; Ulf Albrechtsson; Carl-Gustav Olsson; Berit Olsson; Björn Jonson
Journal:  Clin Physiol Funct Imaging       Date:  2002-11       Impact factor: 2.273

4.  [Indirect MR venography: contrast medium protocols, postprocessing and combination in diagnosing pulmonary emboli with MRI].

Authors:  A Kluge; M Rominger; M Schönburg; G Bachmann
Journal:  Rofo       Date:  2004-07

5.  Dual energy CT of the chest: how about the dose?

Authors:  Jan C Schenzle; Wieland H Sommer; Klement Neumaier; Gisela Michalski; Ursula Lechel; Konstantin Nikolaou; Christoph R Becker; Maximilian F Reiser; Thorsten R C Johnson
Journal:  Invest Radiol       Date:  2010-06       Impact factor: 6.016

Review 6.  Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

7.  Angiogenesis and remodeling of airway vasculature in chronic inflammation.

Authors:  D M McDonald
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

8.  Steal phenomenon-induced lung perfusion defects in pulmonary arteriovenous fistulas: assessment with automated perfusion SPECT-CT fusion images.

Authors:  Kazuyoshi Suga; Hideyuki Iwanaga; Osamu Tokuda; Munemasa Okada; Nobuyuki Tanaka; Naofumi Matsunaga
Journal:  Nucl Med Commun       Date:  2010-09       Impact factor: 1.690

9.  CT pulmonary angiography: a comparative analysis of the utilization patterns in emergency department and hospitalized patients between 1998 and 2003.

Authors:  J David Prologo; Robert C Gilkeson; Mireya Diaz; Joe Asaad
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

10.  Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy.

Authors:  Sven F Thieme; Christoph R Becker; Marcus Hacker; Konstantin Nikolaou; Maximilian F Reiser; Thorsten R C Johnson
Journal:  Eur J Radiol       Date:  2008-09-05       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.